Armstrong, Andrew J.Nixon, Andrew B.Carmack, AndreaYang, QianEisen, TimStadler, Walter M.Jones, Robert J.Garcia, Jorge A.Vaishampayan, Ulka N.Picus, JoelHawkins, Robert E.Hainsworth, John D.Kollmannsberger, Christian K.Logan, Theodore F.Puzanov, IgorPickering, Lisa M.Ryan, Christopher W.Protheroe, AndrewGeorge, Daniel J.Halabi, Susan2022-11-222022-11-222021-06Armstrong, A. J., Nixon, A. B., Carmack, A., Yang, Q., Eisen, T., Stadler, W. M., Jones, R. J., Garcia, J. A., Vaishampayan, U. N., Picus, J., Hawkins, R. E., Hainsworth, J. D., Kollmannsberger, C. K., Logan, T. F., Puzanov, I., Pickering, L. M., Ryan, C. W., Protheroe, A., George, D. J., & Halabi, S. (2021). Correction: Angiokines Associated with Outcomes after Sunitinib or Everolimus Treatment in Patients with Non–Clear Cell Renal Cell Carcinoma. Clinical Cancer Research, 27(12), 3503–3503. https://doi.org/10.1158/1078-0432.CCR-21-16361078-0432, 1557-3265https://hdl.handle.net/1805/30606en-USPublisher PolicyAngiokinesEverolimus TreatmentNon–Clear Cell Renal Cell CarcinomaArticle